<ul>
	<li>History of coronary artery disease or coronary vasospasm</li>
	<li>Wolff-Parkinson-White syndrome or other cardiac accessory conduction pathway disorders</li>
	<li>History of stroke, transient ischemic attack, or hemiplegic or basilar migraine</li>
	<li>Peripheral vascular disease</li>
	<li>Ischemic bowel disease</li>
	<li>Uncontrolled hypertension</li>
	<li>Recent (within 24 hours) use of another 5 HT1 agonist (e.g., another triptan) or of an ergotamine containing&nbsp;medication</li>
	<li>Concurrent or recent (past 2 weeks) use of monoamine oxidase A inhibitor</li>
	<li>Hypersensitivity to sumatriptan (angioedema and anaphylaxis seen)</li>
	<li>Severe hepatic impairment</li>
</ul>